Drug Shortage Report for PRO-CIPROFLOXACIN
Report ID | 212576 |
Drug Identification Number | 02317818 |
Brand name | PRO-CIPROFLOXACIN |
Common or Proper name | CIPROFLOXACIN |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | CIPROFLOXACIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2023-12-06 |
Estimated end date | 2024-02-15 |
Actual end date | 2024-02-16 |
Shortage status | Resolved |
Updated date | 2024-02-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-02-17 | English | Compare |
v7 | 2024-02-16 | French | Compare |
v6 | 2024-02-16 | English | Compare |
v5 | 2024-01-31 | French | Compare |
v4 | 2024-01-31 | English | Compare |
v3 | 2023-12-07 | English | Compare |
v2 | 2023-12-06 | French | Compare |
v1 | 2023-12-06 | English | Compare |
Showing 1 to 8 of 8